A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00387920

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:33.568385+00:00

Published At

2014-01-28T00:00:00+00:00

Record Updated At

2014-01-28

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Central Nervous System Metastases", "Childhood Central Nervous System Choriocarcinoma", "Childhood Central Nervous System Embryonal Tumor", "Childhood Central Nervous System Germ Cell Tumor", "Childhood Central Nervous System Germinoma", "Childhood Central Nervous System Mixed Germ Cell Tumor", "Childhood Central Nervous System Teratoma", "Childhood Central Nervous System Yolk Sac Tumor", "Recurrent Childhood Central Nervous System Embryonal Tumor", "Unspecified Childhood Solid Tumor, Protocol Specific"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-01-28"

protocolSection.identificationModule.nctId

"NCT00387920"

protocolSection.identificationModule.officialTitle

"A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children With Refractory Solid Tumors"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Central Nervous System Metastases (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Choriocarcinoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Embryonal Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Germinoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Mixed Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Teratoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Childhood Central Nervous System Embryonal Tumor (protocolSection.conditionsModule.conditions)
• Unspecified Childhood Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.